Effect of intravenous lidocaine and intravenous magnesium sulfate in reduction of myoclonic movements
Phase 3
Recruiting
- Conditions
- Myoclonus.Drug-induced myoclonus
- Registration Number
- IRCT2017062134674N1
- Lead Sponsor
- Vice chancellor for research, Shahroud University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 117
Inclusion Criteria
patients who candidate for orthopedic surgery
Exclusion criteria: ASA anesthesia risk class 3 and higher; emergency surgery; history of opium, anticonvulsant and sedative drugs; patients with Parkinson; contraindication for lidocaine and magnesium sulfate
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Myoclonus. Timepoint: Within 90 seconds after injection of the main drug for induction of anesthesia. Method of measurement: Observation.
- Secondary Outcome Measures
Name Time Method